SUN PHARMACEUTICAL IND L Financial Ratios
SUNPHARMA · Healthcare · Current price ₹1,932.6
P/E ratio
40.4x
P/B ratio
5.6x
ROE
16.0%
ROCE
21.0%
Debt / Equity
0.06
Dividend yield
0.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 40.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 16.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 21.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.06 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with SUN PHARMACEUTICAL IND L's latest numbers.
SUN PHARMACEUTICAL IND L profitability
SUN PHARMACEUTICAL IND L generates a return on equity of 16.0% and a return on capital employed of 21.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.06 and a P/E of 40.4x, SUN PHARMACEUTICAL IND L is conservatively financed. Our overall business-quality score for the company is 5.3 / 10.
Understand the ratios
More on SUN PHARMACEUTICAL IND L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.